Had a blast talking about how the amended NYSE Rule 452 will benefit shareholders and keep corporate board members on their toes. We also talked about Carl Icahn‘s campaign to take 4 of 9 board seats at Genzyme ($GENZ).
I’m a New York City-based financial advisor at Ritholtz Wealth Management LLC. I help people invest and manage portfolios for them. For disclosure information please see here.
Subscribe & Reform
Get a Full Investor Curriculum: Join The Book List
Every month you'll receive 3-4 book suggestions--chosen by hand from more than 1,000 books. You'll also receive an extensive curriculum (books, articles, papers, videos) in PDF form right away.
… [Trackback]
[…] There you will find 67235 more Information to that Topic: thereformedbroker.com/2010/02/25/stock-wars-episode-3-genzyme-nyse-rule-452/ […]